Trials / Sponsors / Immunome, Inc.
Immunome, Inc.
Industry · 8 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer Solid Malignancies | EARLY_Phase 1 | 2026-04-01 |
| Completed | A Varegacestat Hepatic Impairment Study Healthy Volunteer, Hepatic Impairment (HI) | Phase 1 | 2025-03-07 |
| Recruiting | A Phase 1 Study of IM-1021 in Participants With Advanced Cancer Solid Malignancies, Hematologic Malignancies | Phase 1 | 2025-02-26 |
| Completed | A Phase 1 Mass Balance Study of Varegacestat Healthy Volunteer | Phase 1 | 2025-02-25 |
| Completed | A Cardiac Liability Study of Varegacestat in Healthy Participants Healthy Volunteer | Phase 1 | 2025-02-24 |
| Completed | A Phase 1 Study to Examine the Effects of Itraconazole After Single Dose Administration of Varegacestat (AL102 Healthy Volunteer | Phase 1 | 2024-11-11 |
| Terminated | IMM-BCP-01 in Mild to Moderate COVID-19 SARS-CoV2 Infection, COVID-19 | Phase 1 | 2022-06-03 |
| Active Not Recruiting | A Study of AL102 in Patients With Progressing Desmoid Tumors Desmoid, Desmoid Tumor | Phase 2 / Phase 3 | 2021-03-30 |